Cargando…
Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
Stroke embodies one of the leading causes of death and disability worldwide. We aimed to provide a comprehensive insight into the effectiveness and safety of antiplatelet agents and anticoagulants in the secondary prevention of ischemic stroke or transient ischemic attack. A systematic search for ra...
Autores principales: | Tornyos, Dániel, Bálint, Alexandra, Kupó, Péter, El Abdallaoui, Oumaima El Alaoui, Komócsi, András |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156895/ https://www.ncbi.nlm.nih.gov/pubmed/34063551 http://dx.doi.org/10.3390/life11050447 |
Ejemplares similares
-
Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials
por: Tornyos, Dániel, et al.
Publicado: (2022) -
Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials
por: Szapáry, László, et al.
Publicado: (2022) -
Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
por: Tornyos, Dániel, et al.
Publicado: (2022) -
Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials
por: El Alaoui El Abdallaoui, Oumaima, et al.
Publicado: (2023) -
Individualized or Uniform De-Escalation Strategies for Antiplatelet Therapy in Acute Coronary Syndrome: A Review of Clinical Trials with Platelet Function Testing and Genetic Testing-Based Protocols
por: El Abdallaoui, Oumaima El Alaoui, et al.
Publicado: (2023)